What’s New in Pediatric Cardiac Hemostasis: DOACs, Factor Therapy, and POC Strategies
October 10, 2026
10:00 – 11:30 AM EDT (US)
1.5 CME Credits
Sponsored by the Hemostasis Interest Group of the Congenital Cardiac Anesthesia Society (CCAS), this webinar will highlight the latest advances in hemostatic therapies and point-of-care monitoring for pediatric cardiac patients. Topics include direct oral anticoagulants (DOACs), factor concentrate therapy, and contemporary coagulation testing strategies.
SPEAKERS/TOPICS:
Updates in DOACs in pediatric patients
Andrew Giustini, MD, PhD; Oregon Health and Science University
Upon completion of this presentation, the participant will be able to:
* Summarize the current evidence for DOAC use in pediatric cardiac disease.
* Understand perioperative management strategies for pediatric cardiac patients on DOACs.
Factor concentrates in pediatric cardiac practice
Elena Ashikhmina Swan, MD, PhD; Mayo Clinic
Upon completion of this presentation, the participant will be able to:
* Review the mechanisms of action and indications of fibrinogen concentrate and prothrombin complex concentrates (PCC)
* Highlight recent evidence for factor concentrate use in pediatric cardiac surgery
* Discuss practical application and safety considerations
Point-of-care testing in the pediatric cardiac OR
Zhe Amy Fang, MD, MPH; Ann & Robert H. Lurie Children’s Hospital of Chicago
* Identify currently available point of care technologies available in congenital cardiac surgery.
* Discuss the evidence for the use of different point of care technologies in pediatric cardiac surgery
MODERATORS:
Senior Moderator:
Laura Downey, MD
Children’s Hospital of Atlanta/Emory University
DISCLOSURE: CSL Behring; Chair of a Drug Safety Monitoring Board
Junior Moderator:
Kara E. Furman, MD PhD
Stanford University/ Lucile Packard Children’s Hospital
INTRODUCTIONS:
Rania Abbasi, MD
Riley Children’s Hospital
Manchula Navaratnam, MD
Stanford University/ Lucile Packard Children’s Hospital
SPA Financial Conflict Resolution
Accreditation and Designation
The Society for Pediatric Anesthesia is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CCAS is a Section of the Society for Pediatric Anesthesia. The Society for Pediatric Anesthesia designates this Other (Live and Enduring Material) activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Education Mission Statement
The CCAS Webinar Series will focus on topics of interest to those who provide anesthesia, sedation, pain management, and critical care services to infants and children with heart disease, and adults with congenital heart disease. The overall goals for attendees of the program are to reinforce and enhance their existing fund of knowledge, while introducing them to new and state-of-the-art techniques and information that affect their practice and improve the perioperative care of patients with heart disease.